Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients.
Cassidy J, Twelves C, Cameron D, Steward W, O'Byrne K, Jodrell D, Banken L, Goggin T, Jones D, Roos B, Bush E, Weidekamm E, Reigner B. Cassidy J, et al. Cancer Chemother Pharmacol. 1999;44(6):453-60. doi: 10.1007/s002800051118. Cancer Chemother Pharmacol. 1999. PMID: 10550565 Clinical Trial.
Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis.
Nikolic-Tomasevic Z, Jelic S, Cassidy J, Filipovic-Ljeskovic I, Tomasevic Z. Nikolic-Tomasevic Z, et al. Among authors: cassidy j. Cancer Chemother Pharmacol. 2005 Dec;56(6):594-602. doi: 10.1007/s00280-005-1011-6. Epub 2005 Jul 26. Cancer Chemother Pharmacol. 2005. PMID: 16044340 Clinical Trial.
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial.
Scheithauer W, McKendrick J, Begbie S, Borner M, Burns WI, Burris HA, Cassidy J, Jodrell D, Koralewski P, Levine EL, Marschner N, Maroun J, Garcia-Alfonso P, Tujakowski J, Van Hazel G, Wong A, Zaluski J, Twelves C; X-ACT Study Group. Scheithauer W, et al. Among authors: cassidy j. Ann Oncol. 2003 Dec;14(12):1735-43. doi: 10.1093/annonc/mdg500. Ann Oncol. 2003. PMID: 14630678 Free article. Clinical Trial.
Capecitabine in the treatment of colorectal cancer.
O'Neill VJ, Cassidy J. O'Neill VJ, et al. Among authors: cassidy j. Future Oncol. 2005 Apr;1(2):183-90. doi: 10.1517/14796694.1.2.183. Future Oncol. 2005. PMID: 16555988 Review.
Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.
Twelves C, Boyer M, Findlay M, Cassidy J, Weitzel C, Barker C, Osterwalder B, Jamieson C, Hieke K; Xeloda Colorectal Cancer Study Group. Twelves C, et al. Among authors: cassidy j. Eur J Cancer. 2001 Mar;37(5):597-604. doi: 10.1016/s0959-8049(00)00444-5. Eur J Cancer. 2001. PMID: 11290435 Clinical Trial.
1,347 results